EXM — Exmceuticals Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
Annual balance sheet for Exmceuticals, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2016 June 30th | 2017 June 30th | 2018 June 30th | 2019 June 30th | 2020 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.057 | 0.003 | 0.033 | 0.14 | 0.265 |
| Net Total Receivables | 0.001 | 0.004 | 0.403 | 0.261 | 0.083 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.061 | 0.007 | 0.436 | 0.73 | 0.359 |
| Net Property, Plant And Equipment | 0 | 0 | — | 0.936 | 0.846 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.061 | 0.007 | 0.436 | 2.46 | 1.25 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.015 | 0.105 | 0.192 | 2.07 | 8.29 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 0.015 | 0.105 | 0.192 | 1.93 | 8.14 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.046 | -0.098 | 0.245 | 0.526 | -6.88 |
| Total Liabilities & Shareholders' Equity | 0.061 | 0.007 | 0.436 | 2.46 | 1.25 |
| Total Common Shares Outstanding |